Suboxone

Pain, Itching, Septic Shock + 7 more
Treatment
6 FDA approvals
20 Active Studies for Suboxone

What is Suboxone

NaloxoneThe Generic name of this drug
Treatment SummaryNaloxone is a medication that blocks or reverses the effects of opioid drugs like morphine and fentanyl. It is used to treat drug overdoses which can cause serious symptoms like difficulty breathing and loss of consciousness. Naloxone can be given as an injection, nasal spray, or intravenous (IV) infusion. It is also available in the combination product Suboxone with the opioid medication buprenorphine. Naloxone works quickly but only lasts for a short time, so it is important to monitor the person injected for responsiveness and provide additional doses if needed. It is also important to note that naloxone
Narcanis the brand name
image of different drug pills on a surface
Suboxone Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Narcan
Naloxone
1971
241

Approved as Treatment by the FDA

Naloxone, otherwise called Narcan, is approved by the FDA for 6 uses including Opioids and Pain .
Opioids
Pain
Used to treat moderate Pain in combination with Pentazocine
Septic Shock
Opioid Dependence
Used to treat Opioid Dependence in combination with Buprenorphine
Respiratory Depression
Pain
Used to treat Severe Pain in combination with Pentazocine

Effectiveness

How Suboxone Affects PatientsNaloxone is a medicine that can be used to counteract the effects of opioid overdoses. It wears off faster than opioids, so multiple doses may be needed. Naloxone has a wide range of effectiveness, and is only useful if the person has taken opioids. When administered, naloxone may cause withdrawal symptoms and it should be noted that it may not completely alleviate all symptoms if other drugs are present.
How Suboxone works in the bodyNaloxone is a drug that blocks the effects of opioids. When someone has taken opioids, naloxone can be used to reverse their effects. If someone hasn't taken opioids, naloxone won't have any significant effect.

When to interrupt dosage

The prescribed dosage of Suboxone is dependent upon the determined illness, such as Opioid Dependence, Pain and Septic Shock. The extent of dosage shifts depending on the system of delivery (e.g. Spray, metered or Tablet) as documented in the table below.
Condition
Dosage
Administration
Pain
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Itching
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Septic Shock
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Respiratory Depression
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioid Dependence
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioids
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Pain
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Emergency Care
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioids
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioids
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal

Warnings

Suboxone Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Naloxone may interact with Pulse Frequency
There are 20 known major drug interactions with Suboxone.
Common Suboxone Drug Interactions
Drug Name
Risk Level
Description
(R)-warfarin
Major
The metabolism of (R)-warfarin can be decreased when combined with Naloxone.
(S)-Warfarin
Major
The metabolism of (S)-Warfarin can be decreased when combined with Naloxone.
1,2-Benzodiazepine
Major
The metabolism of 1,2-Benzodiazepine can be decreased when combined with Naloxone.
3,5-diiodothyropropionic acid
Major
The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Naloxone.
5-androstenedione
Major
The metabolism of 5-androstenedione can be decreased when combined with Naloxone.
Suboxone Toxicity & Overdose RiskNaloxone has no significant effect on people who have not taken opioids. The lowest toxic dose in mice and rats when taken orally is greater than 1 g/kg. When given intraperitoneally, the lowest toxic dose is 80 mg/kg in mice and 239 mg/kg in rats. When given subcutaneously, the lowest toxic dose is 286 mg/kg in mice and 500 mg/kg in rats.
image of a doctor in a lab doing drug, clinical research

Suboxone Novel Uses: Which Conditions Have a Clinical Trial Featuring Suboxone?

64 active trials are presently analyzing the potential of Suboxone to treat Opioids Abuse, Pain Management and Opioid Relapse Prevention.
Condition
Clinical Trials
Trial Phases
Opioids
0 Actively Recruiting
Septic Shock
15 Actively Recruiting
Phase 3, Phase 2, Not Applicable, Phase 1, Phase 4
Itching
11 Actively Recruiting
Phase 2, Phase 4, Phase 3, Phase 1
Pain
0 Actively Recruiting
Opioid Dependence
13 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Phase 4, Phase 1, Early Phase 1
Pain
0 Actively Recruiting
Respiratory Depression
0 Actively Recruiting
Opioids
2 Actively Recruiting
Not Applicable, Early Phase 1
Emergency Care
0 Actively Recruiting
Opioids
5 Actively Recruiting
Phase 4, Not Applicable, Phase 1, Phase 2

Suboxone Reviews: What are patients saying about Suboxone?

5Patient Review
1/20/2015
Suboxone for Chronic Pain
This treatment has greatly improved my quality of life by reducing the pain I experience on a day-to-day basis. I highly recommend it to others who are struggling with chronic pain management.
5Patient Review
3/6/2015
Suboxone for Narcotic Addiction
I'm always impressed with how well this treatment works. I feel great after using it!
4.3Patient Review
1/26/2021
Suboxone for Narcotic Addiction
Suboxone has been a game-changer for me. I've only been taking it for a couple weeks, but it's helped immensely. I know the strips aren't ideal, but they're better than going back to using fentanyl.
4.3Patient Review
7/13/2022
Suboxone for Prevention of Opiate Drug Abuse
Suboxone unfortunately causes weight gain in addition to chronic constipation. Unless you're using a laxative daily, be prepared to see the number on the scale go up.
3.7Patient Review
5/8/2022
Suboxone for Narcotic Addiction
They don't tell you that you can get addicted to this medication, and it's harder to stop taking it than it is to start.
3.7Patient Review
1/26/2021
Suboxone for Prevention of Opiate Drug Abuse
I started taking suboxone recently to help wean myself off of fentanyl, and it's going well so far. I haven't experienced any cravings since starting the medication. However, I don't like the strips at all. They taste terrible and it's hard to keep them in place on my tongue. I'm planning on getting off the medication as soon as possible.
3.3Patient Review
1/15/2021
Suboxone for Narcotic Addiction
I am currently tapering off suboxone after being prescribed it for the past three years. I can confirm that the withdrawal symptoms are incredibly difficult, and much worse than coming off of opiates. If you can help it, don't stay on this drug as long as I did. I'm not looking forward to the next six months of depression.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about suboxone

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What does Suboxone do to you mentally?

"Suboxone can have negative effects on the brain and behavior, especially when used incorrectly. Possible side effects include depression, anxiety, and insomnia. Suboxone also has a high potential for being diverted for abuse."

Answered by AI

What do they give you Suboxone for?

"Suboxone is a prescription medication that is used to treat people who are addicted to opioids. It contains two ingredients, Buprenorphine and Naloxone. Buprenorphine is a partial opioid agonist, which means that it blocks the opioid receptors and reduces a person's urges."

Answered by AI

Is Suboxone a painkiller?

"Naloxone — an opiate antagonist that limits the euphoric effects of opioids.

Suboxone is a partial opioid that contains a combination of two components: Buprenorphine, a mild opiate analgesic that helps treat moderate pain, and Naloxone, an opiate antagonist that limits the euphoric effects of opioids. Suboxone is used to treat opioid addiction and chronic pain."

Answered by AI

What kind of opioid is in Suboxone?

"The active ingredient in Suboxone, Buprenorphine, is attractive to both patients and medical professionals treating them because it is a partial agonist of the mu opioid receptor and an antagonist of the kappa receptor."

Answered by AI

Is Suboxone a controlled substance or a narcotic?

"Suboxone is a drug classified as a Schedule III controlled substance in the United States, meaning it is a drug deemed to have medical value yet also carry moderate risk for addiction. Only doctors who receive certifications from the Department of Health and Human Services may prescribe Suboxone."

Answered by AI

Is Suboxone the same as methadone?

"No, methadone and Suboxone have different ingredients. Methadone only has one ingredient, methadone hydrochloride. Suboxone is a combination of two medications, buprenorphine and naloxone."

Answered by AI

What exactly does Suboxone do?

"Suboxone is a prescription medication used in treating those addicted to Opioids, illegal or prescription. It contains the ingredients Buprenorphine and Naloxone. Buprenorphine, a partial Opioid agonist, blocks the Opiate receptors and reduces a person's urges to use Opioids."

Answered by AI

Clinical Trials for Suboxone

Have you considered Suboxone clinical trials? We made a collection of clinical trials featuring Suboxone, we think they might fit your search criteria.
Have you considered Suboxone clinical trials? We made a collection of clinical trials featuring Suboxone, we think they might fit your search criteria.
Have you considered Suboxone clinical trials? We made a collection of clinical trials featuring Suboxone, we think they might fit your search criteria.